Table 1 Background characteristics of the patients (n = 99)
Characteristics | Total | Cefepime | Meropenem | Piperacillin/tazobactam | p-value |
|---|---|---|---|---|---|
Age | 29.87 (14.21) | 34.24 (13.68) | 26.06 (12.82) | 29.30 (15.22) | 0.620 |
Sex | |||||
Male | 63 (63.64) | 18 (54.55) | 22 (66.67) | 23 (69.70) | 0.400 |
Female | 36 (36.36) | 15 (45.45) | 11 (33.33) | 10 (30.30) | |
Diagnosis | |||||
ALL | 38 (38.38) | 8 (24.24) | 17 (51.52) | 13 (39.39) | 0.120 |
AML | 43 (43.43) | 18 (54.55) | 9 (27.27) | 16 (48.48) | |
Others | 18 (18.18) | 7 (21.21) | 7 (21.21) | 4 (12.12) | |
Comorbidity | 8 (8.08) | 3 (9.09) | 1 (3.03) | 4 (12.12) | 0.386 |
Cause of fever | |||||
CDI | 28 (28.28) | 9 (27.27) | 7 (21.21) | 12 (36.36) | 0.388 |
MDI | 31 (31.31) | 12 (36.36) | 10 (30.30) | 9 (27.27) | 0.720 |
PUO | 47 (47.47) | 16 (48.48) | 16 (48.48) | 15 (45.45) | 0.960 |
Treatment duration | 7 (1) | 7 (1) | 7 (1.5) | 7 (2) | 0.769 |
ANC (cells/μl), median (IQR) | 80 (240) | 125 (250) | 90 (390) | 50 (150) | 0.362 |
ANC category (cells/μl) | |||||
< 100 | 51 (51.52) | 15 (45.45) | 17 (51.52) | 19 (57.58) | 0.904 |
100–499 | 31 (31.31) | 12 (36.36) | 10 (30.30) | 9 (27.27) | |
≥ 500 | 17 (17.17) | 6 (18.18) | 6 (18.18) | 5 (15.15) | |